Technical Analysis for DGX - Quest Diagnostics Incorporated

Grade Last Price % Change Price Change
D 128.14 -0.11% -0.14
DGX closed down 0.11 percent on Monday, March 18, 2024, on 76 percent of normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Inside Day Range Contraction 0.00%
20 DMA Support Bullish -0.11%
MACD Bullish Centerline Cross Bullish -0.11%
Pocket Pivot Bullish Swing Setup -0.11%
Inside Day Range Contraction -0.11%
Gapped Down Weakness -0.11%
Stochastic Sell Signal Bearish 0.80%
Expansion Pivot Sell Setup Bearish Swing Setup 0.80%
20 DMA Support Bullish 0.80%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 16 hours ago
60 Minute Opening Range Breakout about 16 hours ago
10 DMA Support about 17 hours ago
20 DMA Support about 19 hours ago
Fell Below 20 DMA about 19 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Quest Diagnostics Incorporated Description

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business offers clinical testing services, including routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights. The Diagnostic Solutions business provides risk assessment services for the life insurance industry; clinical testing services for new drugs, vaccines, and medical devices; and clinical connectivity and data management solutions for healthcare organizations and clinicians to improve patient care and medical practice, as well as develops, manufactures, and markets diagnostics products. Its products include HemoCue, a point-of-care testing product for hemoglobin, glucose, microalbumin, and white blood cell testing; Care360 HER that allows doctors to electronically create, manage, and distribute patient encounter notes; and ChartMaxx, an electronic document management system for hospitals. The company offers its services to patients, physicians, hospitals, integrated delivery networks, health plans, employers, governmental institutions, and other commercial clinical laboratories through a network of laboratories and patient service centers. Quest Diagnostics Incorporated has a strategic alliance with Hologic, Inc. to offer testing based on Hologic's APTIMA family of products, as well as to co-develop and promote advanced diagnostic solutions to improve women's health. The company was founded in 1967 and is headquartered in Madison, New Jersey.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: S&P 500 Medicine Insurance Industry Glucose Lab Testing Diagnostic Products Document Management Healthcare Organizations Risk Assessment Hemoglobin Pathology Anatomical Pathology Medical Diagnosis Radiometer Data Management Solution Diagnostic Solutions Data Management Solutions Document Management System Pathology Services Point Of Care Testing Sunquest Information Systems

Is DGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 146.2331
52 Week Low 118.2734
Average Volume 1,104,625
200-Day Moving Average 131.26
50-Day Moving Average 129.04
20-Day Moving Average 126.72
10-Day Moving Average 127.82
Average True Range 2.42
RSI (14) 51.69
ADX 12.87
+DI 19.01
-DI 19.29
Chandelier Exit (Long, 3 ATRs) 123.99
Chandelier Exit (Short, 3 ATRs) 130.57
Upper Bollinger Bands 130.05
Lower Bollinger Band 123.38
Percent B (%b) 0.71
BandWidth 5.26
MACD Line 0.06
MACD Signal Line -0.37
MACD Histogram 0.4324
Fundamentals Value
Market Cap 14.28 Billion
Num Shares 111 Million
EPS 7.49
Price-to-Earnings (P/E) Ratio 17.11
Price-to-Sales 1.53
Price-to-Book 2.24
PEG Ratio 2.91
Dividend 2.84
Dividend Yield 2.22%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 130.77
Resistance 3 (R3) 130.50 129.35 130.33
Resistance 2 (R2) 129.35 128.68 129.49 130.18
Resistance 1 (R1) 128.75 128.27 129.05 129.02 130.04
Pivot Point 127.60 127.60 127.76 127.74 127.60
Support 1 (S1) 127.00 126.93 127.30 127.27 126.24
Support 2 (S2) 125.85 126.52 125.99 126.10
Support 3 (S3) 125.25 125.85 125.95
Support 4 (S4) 125.52